1 |
Grimm D, Bauer J, Wise P, et al. The role of SOX family members in solid tumours and metastasis[J]. Semin Cancer Biol, 2020, 67(Pt 1): 122-153.
|
2 |
Hawkins K, Joy S, McKay T. Cell signalling pathways underlying induced pluripotent stem cell reprogramming[J]. World J Stem Cells, 2014, 6(5): 620-628.
|
3 |
Chaudhary S, Islam Z, Mishra V, et al. Sox2: a regulatory factor in tumorigenesis and metastasis[J]. Curr Protein Pept Sci, 2019, 20(6): 495-504.
|
4 |
Hur JY, Kim HR, Lee JY, et al. CDK7 inhibition as a promising therapeutic strategy for lung squamous cell carcinomas with a SOX2 amplification[J]. Cell Oncol Dordrecht, 2019, 42(4): 449-458.
|
5 |
Takeda K, Mizushima T, Yokoyama Y, et al. Sox2 is associated with cancer stem-like properties in colorectal cancer[J]. Sci Rep, 2018, 8(1): 17639.
|
6 |
Porter L, McCaughan F. SOX2 and squamous cancers[J]. Semin Cancer Biol, 2020, 67(Pt 1): 154-167.
|
7 |
Rafał S, Szczepan C, Arkadiusz L, et al. Intensity of nuclear staining for ki-67, p53 and survivin as a new prognostic factor in non-muscle invasive bladder cancer[J]. Pathol Oncol Res, 2020, 26(2): 1211-1219.
|
8 |
Lin F, Lin P, Zhao D, et al. Sox2 targets cyclinE, p27 and survivin to regulate androgen-independent human prostate cancer cell proliferation and apoptosis[J]. Cell Prolif, 2012, 45(3): 207-216.
|
9 |
Luo YJ, Liu T, Fei W, et al. Correlation between SOX2 and Survivin clinical features in patients with salivary adenoid cystic carcinoma[J]. J Infect Public Heal, 2019, 12(6): 847-853.
|
10 |
李腊秀, 王科, 赵家宁, 等. 胃癌组织SOX1和β-catenin的表达及其与临床病理特征、远期预后的相关性[J]. 中国现代医学杂志, 2021, 31(13): 30-34.
|
|
Li LX, Wang K, Zhao JN, et al. Expression of SOX1 and β-catenin in gastric cancer and its relationship with pathological characteristics and long-term prognosis[J]. China J Mod Med, 2021, 31(13): 30-34.
|
11 |
Liu XH, Yang XJ, Zhan CN, et al. Perineural invasion in adenoid cystic carcinoma of the salivary glands: where we are and where we need to go[J]. Front Oncol, 2020, 10: 1493.
|
12 |
张晔, 张妮, 刘晓筱, 等. 唾液腺腺样囊性癌淋巴结转移相关的临床病理分析[J]. 北京大学学报(医学版), 2020, 52(1): 30-34.
|
|
Zhang Y, Zhang N, Liu XX, et al. Cervical lymph node metastasis in adenoid cystic carcinoma of the saliva-ry glands: a clinicopathologic study[J]. J Peking Univ (Healt Sci), 2020, 52(1): 30-34.
|
13 |
Terhaard CH, Lubsen H, Van der Tweel I, et al. Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group[J]. Head Neck, 2004, 26(8): 681-693.
|
14 |
Herreros-Villanueva M, Zhang JS, Koenig A, et al. SO-X2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cells[J]. Oncogenesis, 2013, 2(8): e61.
|
15 |
Jia XP, Li XF, Xu YX, et al. SOX2 promotes tumorigenesis and increases the anti-apoptotic property of human prostate cancer cell[J]. J Mol Cell Biol, 2011, 3(4): 230-238.
|
16 |
Kim M, Jang K, Miller P, et al. VEGFA links self-renewal and metastasis by inducing Sox2 to repress miR-452, driving Slug[J]. Oncogene, 2017, 36(36): 5199-5211.
|
17 |
Moore CB, Guthrie EH, Huang MT, et al. Short hairpin RNA (shRNA): design, delivery, and assessment of gene knock down[J]. Methods Mol Biol, 2010, 629: 141-158.
|
18 |
Sandeep S, Jose T, Namrata BS, et al. EGFR/Src/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer[J]. Mol Cancer, 2012, 11(1): 73.
|
19 |
Schaefer T, Lengerke C. SOX2 protein biochemistry in stemness, reprogramming, and cancer: the PI3K/AKT/SOX2 axis and beyond[J]. Oncogene, 2020, 39(2): 278-292.
|